US PTAB IP Litigation

8,722 annotated decisions

8,722
Decisions
1
IP Types
0
Courts
Browse by type: patent 8,722

Page 38 of 364 · 8,722 total

patent terminated or settled · Sep 19, 2025

Harbor Freight Tools USA, Inc. et al. v.Champion Power Equipment, Inc.

· IPR2025-01463

Harbor Freight and Champion Power have settled the IPR over U.S. Patent 11,840,970 covering a dual‑fuel generator. The parties filed a joint request to keep the settlement agreement confidential under 35 U.S.C. §317 and related regulations, and the petitioner seeks to withdraw from the proceeding.

patent · Sep 19, 2025

Dr. Falk Pharma GmbH v.Ellodi Pharmaceuticals

· PGR2025-00086

Dr. Falk Pharma challenges Ellodi's U.S. Patent 12,290,598 covering orally disintegrating tablets, asserting lack of written description, enablement, indefiniteness, anticipation, and obviousness over numerous prior‑art references. The petition seeks cancellation of all 34 claims.

patent · Sep 19, 2025

Bose Corporation v.IngenioSpec, LLC

· IPR2025-01550

Bose Corporation has filed a petition to invalidate IngenioSpec’s U.S. Patent 12,044,901 covering head‑worn electronic devices. The petition asserts lack of priority and anticipatory/obviousness grounds based on Howell‑887 and multiple prior‑art combinations. The PTAB has yet to decide whether to institute the IPR.

patent · Sep 19, 2025

Bose Corporation v.IngenioSpec, LLC

· IPR2025-01549

Bose Corporation filed an IPR petition seeking cancellation of all 32 claims of IngenioSpec’s ’2901 wireless headset patent, asserting lack of priority and obviousness over multiple prior‑art references.

patent · Sep 19, 2025

Bose Corporation v.IngenioSpec, LLC

· IPR2025-01547

Bose Corp. filed an IPR petition challenging all 82 claims of IngenioSpec’s ’789 hearing‑enhancement patent. The petition asserts lack of written‑description support and cites multiple prior‑art references to render the claims anticipated or obvious under §§102 and 103.

patent · Sep 19, 2025

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-01562

Imperative Care has filed an IPR petition challenging Inari Medical’s 12,109,384 patent covering a hemostasis valve. The petitioner alleges obviousness over prior‑art references Schaffer, Hartley, Eller, and Hermann and seeks institution of the review.

patent · Sep 19, 2025

Hisense USA Corp. et al. v.Light Guide Innovations LLC

· IPR2025-01537

Hisense has filed a petition for inter partes review of Light Guide Innovations' U.S. Patent 7,936,415 covering LED backlight modules. The petition asserts seven obviousness grounds based on Roberts and other prior art references, seeking cancellation of all 18 claims.

patent · Sep 19, 2025

Google LLC v.K.Mizra LLC

· IPR2025-01437

Google has filed an IPR petition seeking to invalidate claims 1‑20 of K.Mizra’s network‑quarantine patent, arguing obviousness over prior art (Freund, Ball, Pujare) and urging the Board to institute trial after a prior institution denial was deemed erroneous.

patent · Sep 19, 2025

Google LLC v.K.Mizra LLC

· IPR2025-01436

Google has filed an IPR petition challenging all 19 claims of K.Mizra’s ’705 patent covering network quarantine and remediation. The petition relies on obviousness over Freund, Ball, Pujare, and Lewis, and cites a Federal Circuit remand of a prior Cisco IPR.

patent · Sep 19, 2025

BOE Technology Group Co., Ltd. v.Samsung Display Co., Ltd.

· IPR2025-01557

BOE Technology Group has filed an IPR petition challenging Samsung Display’s 7,279,708 OLED display patent. The petition argues that all asserted claims are obvious over four prior‑art references and urges the PTAB to institute the review.

patent · Sep 19, 2025

Bose Corporation v.IngenioSpec, LLC

· IPR2025-01548

Bose Corporation filed an IPR petition seeking to invalidate all 20 claims of IngenioSpec’s ‘518 headset patent, arguing that each claim is obvious over a series of prior‑art headset references. The petition groups the challenges into multiple obviousness grounds covering the full claim set.

patent · Sep 19, 2025

Harbor Freight Tools USA, Inc. et al. v.Champion Power Equipment, Inc.

· IPR2025-01463

Harbor Freight, Generac and MWE have petitioned the PTAB to institute an IPR against Champion Power Equipment's 11,840,970 dual‑fuel generator patent. The petition alleges obviousness over numerous prior‑art references and challenges the claim language as means‑plus‑function under §112(f).

patent · Sep 19, 2025

Taiwan Semiconductor Manufacturing Company Ltd. v.Marlin Semiconductor Limited et al.

· IPR2025-01444

TSMC has filed an IPR petition challenging Marlin Semiconductor’s U.S. 7,547,584 patent covering dummy openings for charge‑damage reduction in dual‑damascene processing. The petition asserts obviousness over six prior‑art references and seeks cancellation of claims 1‑6.

patent instituted · Sep 19, 2025

Dr. Falk Pharma GmbH v.Ellodi Pharmaceuticals

· PGR2025-00086

The PTAB granted institution for the PGR proceeding involving Dr. Falk Pharma and Ellodi Pharmaceuticals, allowing the challenge to move forward.

patent instituted · Sep 19, 2025

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-01562

The USPTO granted institution for several Inter Partes Review proceedings after petitioners demonstrated a reasonable likelihood of prevailing on their challenges. Other cases were denied based on discretionary or merits reviews.

patent instituted · Sep 19, 2025

Taiwan Semiconductor Manufacturing Company Ltd. v.Marlin Semiconductor Limited et al.

· IPR2025-01444

The PTAB granted institution for IPR2025-01444, allowing Taiwan Semiconductor Manufacturing Company Ltd. to challenge the patent held by Marlin Semiconductor Limited et al., based on a reasonable likelihood of prevailing.

patent · Sep 18, 2025

BOE Technology Group Co., Ltd. v.Paneltouch Technologies, LLC

· IPR2025-01483

BOE Technology filed an IPR petition seeking to invalidate all 21 claims of Paneltouch's 2016 touchscreen display patent, arguing obviousness over multiple prior‑art references.

patent · Sep 18, 2025

BOE Technology Group Co., Ltd. v.Paneltouch Technologies, LLC

· IPR2025-01482

BOE Technology Group has filed an IPR petition challenging Paneltouch Technologies' 8,704,762 display device patent, asserting that the claims are obvious over several prior‑art references covering crack‑detection wiring in touch and display panels.

patent · Sep 17, 2025

Alvotech USA Inc. et al. v.Regeneron Pharmaceuticals, Inc.

· PGR2025-00085

Alvotech petitions the PTAB to invalidate Regeneron’s ’036 patent covering high‑dose aflibercept eye‑treatment formulations, alleging obviousness and lack of written description. The petition relies on multiple Regeneron disclosures and external prior art. The Board has yet to rule.

patent · Sep 17, 2025

SHENZHEN QIANFENYI INTELLIGENT TECHNOLOGY CO., LTD. v.Wacom Co. Ltd.

· IPR2025-01556

Shenzhen Qianfenyi (Maxeye) has filed an IPR petition seeking to invalidate Wacom’s ’220 patent on active‑stylus communication, asserting that all challenged claims are anticipated or obvious over six prior‑art references.

patent · Sep 17, 2025

Samsung Electronics Co., Ltd. et al. v.One-E-Way, Inc.

· IPR2025-01541

Samsung Electronics petitions the PTAB to institute an IPR against One‑E‑Way’s 9,107,000 patent covering wireless digital audio systems, challenging ten claims on priority and obviousness grounds.

patent instituted · Sep 17, 2025

Alvotech USA Inc. et al. v.Regeneron Pharmaceuticals, Inc.

· PGR2025-00085

The PTAB granted institution for the PGR proceeding (PGR2025-00085) involving Alvotech and Regeneron regarding patent 12168036. The petitioner met the likelihood of prevailing standard.

patent instituted · Sep 17, 2025

Samsung Electronics Co., Ltd. et al. v.One-E-Way, Inc.

· IPR2025-01541

The USPTO granted institution for IPR2025-01541 after determining the petitioner had a reasonable likelihood of prevailing. This decision moves the case forward to merits review.

patent · Sep 16, 2025

Samsung Electronics Co., Ltd. et al. v.One-E-Way, Inc.

· IPR2025-01540

Samsung Electronics has filed a petition for inter partes review of One‑E‑Way’s U.S. Patent 10,129,627 covering wireless digital audio spread‑spectrum technology, seeking cancellation of all twelve claims on priority and obviousness grounds.

1 •••373839•••364